Published in Wien Klin Wochenschr on January 01, 2007
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev (2004) 11.69
Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med (1995) 9.02
Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell (1992) 4.90
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci (1995) 4.83
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer (1998) 3.93
Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res (1990) 3.35
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med (1994) 2.54
Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci U S A (1990) 2.09
Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol (1993) 1.93
Continuing controversies in the management of thyroid nodules. Ann Intern Med (2005) 1.70
AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun (1992) 1.60
The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab (1983) 1.13
Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest (1995) 1.08
Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun (1991) 0.98
Pathogenesis of thyroid nodules: histological classification? Biomed Pharmacother (2001) 0.97
Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density. Hum Pathol (2001) 0.96
Goitre epidemiology: thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) (1986) 0.95
Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules. J Clin Endocrinol Metab (1997) 0.90
Precocity of the endothelial proliferation during a course of rapid goitrogenesis. Acta Endocrinol (Copenh) (1984) 0.83
Serum and synovial fluid concentration of vascular endothelial growth factor in juvenile idiopathic arthritides. Rheumatology (Oxford) (2002) 0.80
[Imaging of diseases of the thyroid gland in Austria]. Wien Klin Wochenschr (2003) 0.77
No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid (2008) 2.26
Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab (2004) 1.92
The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg (2011) 1.88
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol (2005) 1.70
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging (2004) 1.67
Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts. Eur J Nucl Med Mol Imaging (2006) 1.65
Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol (2005) 1.65
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil. Epilepsia (2007) 1.55
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging (2008) 1.55
Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy? Clin Endocrinol (Oxf) (2002) 1.53
[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme. J Neurooncol (2007) 1.51
Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine. Thyroid (2012) 1.39
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest (2003) 1.21
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans. Clin Pharmacol Ther (2005) 1.19
Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels. Anesthesiology (2009) 1.17
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. J Nucl Med (2004) 1.12
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging (2004) 1.09
Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol (Oxf) (2003) 1.07
Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol (2008) 1.06
Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) (2008) 1.05
Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid (2002) 1.04
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer (2003) 1.02
Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid (2010) 1.02
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer. J Clin Oncol (2006) 1.01
Genome sequence of Rhodococcus sp. strain R04, a polychlorinated-biphenyl biodegrader. J Bacteriol (2011) 1.00
Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis? Clin Endocrinol (Oxf) (2003) 0.99
Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: comparison of 2 tracer kinetic models. J Nucl Cardiol (2005) 0.99
PET based volume segmentation with emphasis on the iterative TrueX algorithm. Z Med Phys (2011) 0.99
Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol (2003) 0.98
Posterior "Nutcracker" phenomenon in a patient with abdominal aortic aneurysm. Eur Radiol (2002) 0.98
Concomitant hyperparathyroidism and nonmedullary thyroid cancer, with a review of the literature. Clin Nucl Med (2003) 0.97
Preparation and first evaluation of [(18)F]FE@SUPPY: a new PET tracer for the adenosine A(3) receptor. Nucl Med Biol (2008) 0.93
Renal elimination of sclerostin increases with declining kidney function. J Clin Endocrinol Metab (2013) 0.93
Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab (2007) 0.93
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. Int Clin Psychopharmacol (2009) 0.92
Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients. Clin Endocrinol (Oxf) (2006) 0.90
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med (2005) 0.90
Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma. Liver Int (2006) 0.89
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. Psychopharmacology (Berl) (2007) 0.89
Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients. J Diabetes Complications (2007) 0.88
Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP. Nucl Med Biol (2007) 0.88
Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2--comparison with conventional radiosyntheses. Nucl Med Biol (2010) 0.87
Typical chest pain and normal coronary angiogram: cardiac risk factor analysis versus PET for detection of microvascular disease. J Nucl Med (2007) 0.87
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther (2006) 0.87
Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) (2005) 0.86
Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncol (2010) 0.86
99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer. J Clin Endocrinol Metab (2006) 0.86
Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET. J Nucl Med (2004) 0.86
Imaging of appendicitis in children and adolescents: useful or useless? A comparison of imaging techniques and a critical review of the current literature. Semin Roentgenol (2008) 0.85
Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging (2002) 0.85
Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg (2012) 0.84
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function. J Clin Endocrinol Metab (2014) 0.84
The prognostic value of IL-8 for cardiac events and restenosis in patients with coronary heart diseases after percutaneous coronary intervention. Jpn Heart J (2003) 0.84
The stability of methyl-, ethyl- and fluoroethylesters against carboxylesterases in vitro: there is no difference. Nucl Med Biol (2010) 0.83
Radiolabeling of [18F]altanserin - a microfluidic approach. Nucl Med Biol (2012) 0.83
[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans. Antimicrob Agents Chemother (2004) 0.82
Adequately adapted insulin secretion and decreased hepatic insulin extraction cause elevated insulin concentrations in insulin resistant non-diabetic adrenal incidentaloma patients. PLoS One (2013) 0.82
Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2006) 0.82
Tc-99m-labeled human polyclonal immunoglobulin G (HIG) scintigraphy in Sjögren's syndrome. Scand J Rheumatol (2002) 0.82
Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur Neuropsychopharmacol (2006) 0.82
Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET. Nucl Med Biol (2004) 0.81
Systemic lidocaine inhibits remifentanil-induced hyperalgesia via the inhibition of cPKCgamma membrane translocation in spinal dorsal horn of rats. J Neurosurg Anesthesiol (2009) 0.81
Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. Jpn Heart J (2003) 0.81
[18F]FE@SUPPY and [18F]FE@SUPPY:2--metabolic considerations. Nucl Med Biol (2010) 0.81
New aspects on the preparation of [11C]Methionine--a simple and fast online approach without preparative HPLC. Appl Radiat Isot (2005) 0.81
Cardiometabolic phenotyping of patients with familial hypocalcuric hypercalcemia. J Clin Endocrinol Metab (2014) 0.80
Inflammatory cytokine release in patients with unstable angina after coronary angioplasty. Jpn Heart J (2002) 0.80
18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers. Nucl Med Biol (2007) 0.80
FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol (2002) 0.80
No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy. J Clin Endocrinol Metab (2014) 0.80
[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers. Eur J Nucl Med Mol Imaging (2006) 0.80
Effects of anesthetic isoflurane and desflurane on human cerebrospinal fluid Aβ and τ level. Anesthesiology (2013) 0.79
Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med (2007) 0.79
Selenium intake and selenium blood levels: a novel food frequency questionnaire. Wien Klin Wochenschr (2013) 0.78
Systemic administration of lidocaine reduces morphine requirements and postoperative pain of patients undergoing thoracic surgery after propofol-remifentanil-based anaesthesia. Eur J Anaesthesiol (2010) 0.78
[18F]FETO: metabolic considerations. Eur J Nucl Med Mol Imaging (2006) 0.78
NCA nucleophilic radiofluorination on substituted benzaldehydes for the preparation of [18F]fluorinated aromatic amino acids. Appl Radiat Isot (2005) 0.78
Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand. Int J Neuropsychopharmacol (2006) 0.78
T-lymphocyte cytokine production patterns in nonimmune severe hypothyroid state and after thyroid hormone replacement therapy. Thyroid (2004) 0.78
Model-based analysis of electrocardiography-gated cardiac (18)F-FDG PET images to assess left ventricular geometry and contractile function. J Nucl Med (2003) 0.77
ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis. Eur J Nucl Med Mol Imaging (2002) 0.77
HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA. Endocr Pract (2016) 0.77
Appointments at a thyroid outpatient clinic and the lunar cycle. Wien Klin Wochenschr (2003) 0.77
A simple micro-photometric method for urinary iodine determination. Clin Chem Lab Med (2011) 0.77
A Case of simultaneous occurrence of Marine - Lenhart syndrome and a papillary thyroid microcarcinoma. BMC Endocr Disord (2013) 0.77
Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients. Thromb Haemost (2004) 0.77
Preparation and pre-vivo evaluation of no-carrier-added, carrier-added and cross-complexed [(68)Ga]-EDTMP formulations. Eur J Pharm Biopharm (2007) 0.77
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study. Eur J Nucl Med Mol Imaging (2003) 0.76
'Suppressed' double adenoma--a rare pitfall in minimally invasive parathyroidectomy. Horm Res (2002) 0.76
Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment. Wien Klin Wochenschr (2002) 0.76
T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation. Anticancer Res (2007) 0.76
Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides. Eur J Nucl Med Mol Imaging (2004) 0.76
Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis. Anticancer Res (2006) 0.76
(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas. Anticancer Res (2014) 0.76
Comparison of three different purification methods for the routine preparation of [11C] Metomidate. Appl Radiat Isot (2003) 0.76